Dinsart C - Search Results

1

Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment.

Dempe S, Lavie M, Struyf S, Bhat R, Verbeke H, Paschek S, Berghmans N, Geibig R, Rommelaere J, Van Damme J, Dinsart C. Dempe S, et al. Among authors: dinsart c. Cancer Immunol Immunother. 2012 Nov;61(11):2113-23. doi: 10.1007/s00262-012-1279-4. Epub 2012 May 11. Cancer Immunol Immunother. 2012. PMID: 22576056 Free PMC article.

2

MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells.

Wetzel K, Struyf S, Van Damme J, Kayser T, Vecchi A, Sozzani S, Rommelaere J, Cornelis JJ, Dinsart C. Wetzel K, et al. Among authors: dinsart c. Int J Cancer. 2007 Mar 15;120(6):1364-71. doi: 10.1002/ijc.22421. Int J Cancer. 2007. PMID: 17154174

3

Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects.

Struyf S, Proost P, Vandercappellen J, Dempe S, Noyens B, Nelissen S, Gouwy M, Locati M, Opdenakker G, Dinsart C, Van Damme J. Struyf S, et al. Among authors: dinsart c. Eur J Immunol. 2009 Mar;39(3):843-57. doi: 10.1002/eji.200838660. Eur J Immunol. 2009. PMID: 19224633 Free article.

4

Enhancement of NK cell antitumor responses using an oncolytic parvovirus.

Bhat R, Dempe S, Dinsart C, Rommelaere J. Bhat R, et al. Among authors: dinsart c. Int J Cancer. 2011 Feb 15;128(4):908-19. doi: 10.1002/ijc.25415. Int J Cancer. 2011. PMID: 20473905

5

Recombinant Parvoviruses Armed to Deliver CXCL4L1 and CXCL10 Are Impaired in Their Antiangiogenic and Antitumoral Effects in a Kaposi Sarcoma Tumor Model Due To the Chemokines' Interference with the Virus Cycle.

Dinsart C, Pervolaraki K, Stroh-Dege A, Lavie M, Ronsse I, Rommelaere J, Van Damme J, Van Raemdonck K, Struyf S. Dinsart C, et al. Hum Gene Ther. 2017 Mar;28(3):295-306. doi: 10.1089/hum.2016.108. Epub 2016 Dec 29. Hum Gene Ther. 2017. PMID: 28042949

6

SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV.

Dempe S, Stroh-Dege AY, Schwarz E, Rommelaere J, Dinsart C. Dempe S, et al. Among authors: dinsart c. Int J Cancer. 2010 Jun 15;126(12):2914-27. doi: 10.1002/ijc.24992. Int J Cancer. 2010. PMID: 19856310

7

Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis.

Lavie M, Struyf S, Stroh-Dege A, Rommelaere J, Van Damme J, Dinsart C. Lavie M, et al. Among authors: dinsart c. Virology. 2013 Dec;447(1-2):221-32. doi: 10.1016/j.virol.2013.09.019. Epub 2013 Oct 4. Virology. 2013. PMID: 24210118 Free article.

8

Vectors based on autonomous parvoviruses: novel tools to treat cancer?

Cornelis JJ, Salomé N, Dinsart C, Rommelaere J. Cornelis JJ, et al. Among authors: dinsart c. J Gene Med. 2004 Feb;6 Suppl 1:S193-202. doi: 10.1002/jgm.502. J Gene Med. 2004. PMID: 14978762 Review.

9

Cancer gene therapy through autonomous parvovirus--mediated gene transfer.

Cornelis JJ, Lang SI, Stroh-Dege AY, Balboni G, Dinsart C, Rommelaere J. Cornelis JJ, et al. Among authors: dinsart c. Curr Gene Ther. 2004 Sep;4(3):249-61. doi: 10.2174/1566523043346228. Curr Gene Ther. 2004. PMID: 15384939 Review.

10

Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1.

Moehler M, Sieben M, Roth S, Springsguth F, Leuchs B, Zeidler M, Dinsart C, Rommelaere J, Galle PR. Moehler M, et al. Among authors: dinsart c. BMC Cancer. 2011 Oct 26;11:464. doi: 10.1186/1471-2407-11-464. BMC Cancer. 2011. PMID: 22029859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters